Houston-based University of Texas MD Anderson Cancer Center has launched the Institute for Cell Therapy Discovery & Innovation. Research at the institute will focus on immunology and cell engineering with the purpose of creating new treatments for cancer and autoimmune…
The Latest
Altamonte Springs, Fla.-based AdventHealth has launched a pilot program designed to harness AI to assess a patient's risk of developing breast cancer.
A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial.
Seattle-based Fred Hutch Cancer Center and NASA have partnered on a pediatric cancer program that aims to alleviate patient fears about radiation therapy.
Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center had the lowest rate of methicillin-resistant Staphylococcus aureus infections for hospitals exempt from reporting to Medicare's Inpatient Prospective Payment System.
By 2050, the number of worldwide cancer cases and deaths will rise to 35.3 million and 18.5 million, respectively, according to a Nov. 5 study published in JAMA Open Network.
CMS released its 2025 Physician Fee Schedule Nov. 1, finalizing a conversion factor of $32.35, down 2.83% from $33.29 in 2024.
A team from Morgantown, W.Va.-based WVU Cancer Institute has become the first in the world to commercially use a new, FDA-approved medical device designed to lower the risk of esophageal cancer.
Houston-based University of Texas MD Anderson Cancer Center has appointed Jennifer Bickel, MD, as the center's first vice president and chief wellness officer.
Newport Beach, Calif.-based Hoag has launched an oncoplastic breast surgery fellowship, the first fellowship of its kind in the U.S.